ロード中...
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve as targets in precise therapy. Using next-generation sequencing (NGS), these aberrant alterations can be identified and used to de...
保存先:
| 出版年: | J Hematol Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7532113/ https://ncbi.nlm.nih.gov/pubmed/33008426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-00958-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|